In September, Vertex filed for Chapter 11 bankruptcy protection and accused Irving, Texas-based Matheson Tri-Gas Inc. of ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $57.33, along ...

Fintel reports that on December 31, 2024, DA Davidson initiated coverage of Vertex (NasdaqGM:VERX) with a Buy recommendation.

NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $402.70, indicating a +0.84% change from the previous session's end. This change outpaced the S&P 500's 0.43% loss on the day. At the ...

DA Davidson analyst William Jellison initiated coverage on Vertex, Inc. VERX with a Buy rating and announced a price target ...

VANCOUVER, BC / ACCESSWIRE / / Mako Mining Corp. ("Mako") (TSXV:MKO)(OTCQX:MAKOF) is pleased to announce the entering into of ...

Elevation Gold Mining Corporation (the "Company" or "Elevation Gold") previously announced in its press release dated December 4, 2024 that it entered into a purchase and sale agreement dated December ...

Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 41.37 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...

New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...